Clinical Trial Update: Is Saxenda® a Viable Treatment of Obese Patients in Forensic Psychiatry? [Phase 4]

View source ↗

Summary

Phase 4 trial update examining whether Saxenda (liraglutide) is a viable treatment for overweight/obesity in patients with mental health and metabolic disturban…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mental Disorder
• Metabolic Disturbance
• Obesity

Drugs mentioned

• SAXENDA (liraglutide)

Snippet

Sponsor: Anders Fink-Jensen, MD, DMSci | Conditions: Mental Disorder, Metabolic Disturbance | Phase 4 | Status: COMPLETED